Search

everythinglearnresearchcommunity

for

Search:↓

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Convalescent Plasma Therapy may help treat COVID-19 Long-Hauler symptoms.

TNF-alpha inhibitors can cause various immune-related skin issues.

Molybdenum oxide nanozymes can effectively treat and monitor acute kidney injury by reducing oxidative stress.

Botulinum toxin type A helps treat hair loss by stopping cell death in hair follicles through a process involving certain non-coding RNAs and a protein called Bax.

Injecting certain cells into mice caused hair loss, which was preventable with a specific inhibitor.

Myeloid-derived suppressor cells help control autoimmune cells and promote hair regrowth in alopecia areata.

Enhancing immune response can improve cancer treatment effectiveness.

A woman with lupus had blood cell destruction, treated successfully with medication.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Anti-MND antibodies are present in various diseases, not just PBC, and their levels don't correlate with disease activity or skin symptoms.

False high testosterone levels were corrected using a more accurate test.

Modified superoxide dismutase may trigger an autoimmune response in alopecia areata.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

Epitestosterone may counteract testosterone's effects and has roles in body processes like prostate growth and hair distribution.

Dupilumab can both improve and worsen alopecia areata, with higher IgE levels linked to better outcomes.

The right dosage of CPA and TB can work as a safe and reversible male contraceptive in monkeys.

Machine learning can help identify biomarkers for personalized Pemphigus vulgaris treatment.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

A woman with severe angioedema improved significantly after treatment with rituximab.

Finasteride is an effective and well-tolerated treatment for hirsutism.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Immune cell-targeting biologics show potential for treating alopecia areata but need better-targeted therapies.